Universal access to GLP-1 receptor agonists for eligible populations could reduce global obesity prevalence by half and save ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

Eli Lilly’s tirzepatide is expected to be worth $62 billion annually by 2030, according to Evaluate. That valuation would be ...

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...

An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in patients with ...

Male Reddit users are reporting what they call "Ozempic penis," with some claiming penile growth of up to 1.5 inches. However ...

FAIR Health data released this month showed more than 2% of adult patients now take a GLP-1 drug to treat overweight or ...

A $10.2 million savings across more than 100,000 prescriptions over three months, extrapolated across the nearly 33 million Americans currently taking GLP-1 medications monthly, indicates a potential ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

A unique business structure gives LifeMD access to the growing GLP-1 marketplace that can help boost the heavily shorted stock price. Read an analysis of LFMD here.

A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...